|
2024
|
Invention
|
Methods of treating injuries or conditions related to cns edema.
The present technology is relat... |
|
|
Invention
|
Low-sorbing glyburide formulation and methods.
Methods and formulations for minimizing or avoidi... |
|
2023
|
Invention
|
Methods of intravenous administration of glyburide.
The present disclosure is drawn to a method ... |
|
2022
|
Invention
|
Low-sorbing glyburide formulation and methods. Methods and formulations for minimizing or avoidin... |
|
2021
|
Invention
|
Methods of medical treatment with sur1-trpm4 channel inhibitors.
A method of treating or prevent... |
|
|
Invention
|
Methods of treating injuries or conditions related to cns edema. The present technology is relate... |
|
2020
|
Invention
|
Formulations and methods for lyophilization and lyophilates provided thereby.
The present invent... |
|
|
Invention
|
Methods of intravenous administration of glyburide. The present disclosure is drawn to a method o... |
|
|
Invention
|
Composition containing glibenclamide.
NSC antagonists are disclosed as useful in the treatment o... |
|
|
Invention
|
Method for treating subjects suffering from central nervous system contusions.
Methods of inhibi... |
|
2019
|
Invention
|
Composition containing glibenclamide. NSC antagonists are disclosed as useful in the treatment of... |
|
|
Invention
|
Formulations and methods for lyophilization and lyophilates provided thereby. The present inventi... |
|
2017
|
Invention
|
Methods of medical treatment with sur1-trpm4 channel inhibitors. A method of treating or preventi... |
|
|
Invention
|
Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer... |
|
2016
|
Invention
|
Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial ... |
|
|
Invention
|
Liquid formulations of compounds active at sulfonylurea receptors. The invention provides liquid ... |
|
2013
|
Invention
|
++ activated atp-sensitive cation channels regulated by sur1 channels. NSC antagonists are disclo... |
|
2011
|
Invention
|
Methods of intravenous administration of glyburide and other drugs. Methods of administering glyb... |
|
|
Invention
|
Methods of intravenous administration of glyburide and other drugs. The invention provides a use ... |
|
|
Invention
|
Methods of intravenous administration of glyburide and other drugs. Abstract of the disclosure Th... |
|
|
Invention
|
Methods of intravenous adminstration of glyburide and other drugs. The invention provides a use o... |
|
2009
|
Invention
|
Liquid formulations of compounds active at sulfonylurea receptors.
The invention provides liquid... |
|
2008
|
Invention
|
Improved formulations and methods for lyophilization and lyophilates provided thereby. The presen... |
|
|
Invention
|
Improved glibenclamide formulations and methods for lyophilization thereof and lyophilates provid... |
|
2007
|
Invention
|
Treatment of alzheimer's disease using compounds that reduce the activity of non selective ca act... |
|
|
Invention
|
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- ... |
